Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Axofit is a fixed-dose combination product marketed by SSK Pharma, an Indian pharmaceutical company. It is composed of methylcobalamin, alpha lipoic acid, and a complex of vitamins. Methylcobalamin is an active form of vitamin B12 that supports neuronal health by promoting the synthesis of the myelin sheath and regenerating damaged nerves. Alpha lipoic acid is a versatile antioxidant that helps neutralize free radicals and improve glucose utilization, which is particularly beneficial in managing diabetic neuropathy. The additional vitamins in the formulation provide essential cofactors for metabolic processes. Axofit is indicated for the treatment of peripheral neuropathy, diabetic neuropathy, and general nutritional deficiencies.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Axofit.